NEW YORK, Feb. 2 (GenomeWeb News) - Agendia, a Dutch firm that specializes in gene-expression services, has signed an agreement with Arcturus Bioscience to license the company's exclusive European rights to its Tumor of Unknown Origin(TUO)-gene expression profile, the companies said today.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.